Primary Country (Mandatory)

Other Country (Optional)

Set News Language for United States

Primary Language (Mandatory)
Other Language[s] (Optional)
No other language available

Set News Language for World

Primary Language (Mandatory)
Other Language(s) (Optional)

Set News Source for United States

Primary Source (Mandatory)
Other Source[s] (Optional)

Set News Source for World

Primary Source (Mandatory)
Other Source(s) (Optional)
  • Countries
    • India
    • United States
    • Qatar
    • Germany
    • China
    • Canada
    • World
  • Categories
    • National
    • International
    • Business
    • Entertainment
    • Sports
    • Special
    • All Categories
  • Available Languages for United States
    • English
  • All Languages
    • English
    • Hindi
    • Arabic
    • German
    • Chinese
    • French
  • Sources
    • India
      • AajTak
      • NDTV India
      • The Hindu
      • India Today
      • Zee News
      • NDTV
      • BBC
      • The Wire
      • News18
      • News 24
      • The Quint
      • ABP News
      • Zee News
      • News 24
    • United States
      • CNN
      • Fox News
      • Al Jazeera
      • CBSN
      • NY Post
      • Voice of America
      • The New York Times
      • HuffPost
      • ABC News
      • Newsy
    • Qatar
      • Al Jazeera
      • Al Arab
      • The Peninsula
      • Gulf Times
      • Al Sharq
      • Qatar Tribune
      • Al Raya
      • Lusail
    • Germany
      • DW
      • ZDF
      • ProSieben
      • RTL
      • n-tv
      • Die Welt
      • Süddeutsche Zeitung
      • Frankfurter Rundschau
    • China
      • China Daily
      • BBC
      • The New York Times
      • Voice of America
      • Beijing Daily
      • The Epoch Times
      • Ta Kung Pao
      • Xinmin Evening News
    • Canada
      • CBC
      • Radio-Canada
      • CTV
      • TVA Nouvelles
      • Le Journal de Montréal
      • Global News
      • BNN Bloomberg
      • Métro
Laurus Labs to make HIV drug for children

Laurus Labs to make HIV drug for children

The Hindu
Tuesday, September 14, 2021 05:12:05 PM UTC

Laurus Labs is developing a generic, fixed-dose combination of paediatric version of darunavir boosted with ritonavir (DRV/r) for use as second- and third-line treatment of HIV.This follows an agreeme

Laurus Labs is developing a generic, fixed-dose combination of paediatric version of darunavir boosted with ritonavir (DRV/r) for use as second- and third-line treatment of HIV.

This follows an agreement Unitaid, Clinton Health Access Initiative (CHAI) and the company entered into in June to accelerate the development, commercialisation and registration of a best-in-class second- and third-line HIV treatment. A generic, fixed-dose combination paediatric version is not available though DRV/r has been available in high-income countries for over 15 years.

Under the programme, Laurus will be provided with a financial incentive for a portion of its development and commercialisation costs. CHAI will work with it to provide technical and regulatory support to enable accelerated generic development and regulatory submission of the medication, the drugmaker said in a release on Tuesday.

Read full story on The Hindu
Share this story on:-
More Related News
“Energy storage, green hydrogen to fundamentally reshape India’s renewable energy ecosystem”

In the next five years, technologies like energy storage and green hydrogen would fundamentally reshape India’s renewable energy ecosystem, says a top company official.

How India’s oil basket has changed over the years

Historically, energy security for the world’s third-largest oil consumer India has been about navigating the prevailing geopolitics whilst ensuring a positive economics for purchase of crude oil purchases.

How India secured RCEP’s advantages without exposing itself to the ‘China risk’

India leverages trade agreements with RCEP countries, strategically avoiding risks associated with China while maximizing market access.

IndiGo faces ₹13 lakh penalty related to GST

IndiGo contests a ₹13 lakh GST penalty imposed by Punjab's tax department, claiming the ruling is erroneous.

Will Indians still ride the gold wave in 2026?

Indian investors had a tumultuous year as the benchmark Nifty returns dipped to negative with overall market turnover hitting a low in December 2025. Howeve, investor interest in gold exchange traded funds (ETFs) increased this year.

Silver soars ₹9,350 to record ₹2.36 lakh/kg in Delhi; crosses $75/ounce mark in international markets

Silver prices surge to a record ₹2.36 lakh/kg in Delhi, fueled by strong global demand and market trends.

Coal Ministry notifies rules doing away with CCO nod for opening, restarting coal mines

Coal Ministry's new rules eliminate CCO approval for opening mines, expediting operations and enhancing efficiency in coal production.

India imposes anti-dumping duty on two Chinese products

India imposes anti-dumping duties on Chinese steel and refrigerant gas to protect domestic industries from unfair pricing.

Sensex declines for third day, sheds 367 points on foreign fund outflows

Sensex declines for the third day, losing 367 points due to foreign fund outflows and thin trading conditions.

Bitcoin volatility, stablecoin regulations, and North Korean hacks: Crypto events that marked 2025

Let’s take a look at some of the biggest crypto events of the year.

Silver futures hit new peak of ₹2.32 lakh/kg as global prices cross $75-mark

Silver futures soar to ₹2.32 lakh/kg as global prices exceed $75, marking a record high in commodities trading.

Stock markets trade lower in early deals

Stock markets decline as Sensex and Nifty fall amid foreign fund outflows and low trading volumes on December 26, 2025.

Rupee falls 23 paise to 89.94 against U.S. dollar in early trade

Rupee drops 23 paise to 89.94 against the dollar amid negative equity trends and rising crude prices.

Sensex sheds 346 points, declines for fourth day on foreign fund outflows, thin year-end trading

Sensex drops 346 points for the fourth consecutive day amid foreign fund outflows and low year-end trading activity.

Rupee falls 8 paise to close at 89.98 against U.S. dollar

The rupee fell 8 paise to 89.98 against the dollar amid foreign fund outflows and increased importer demand.

Rupee vs dollar: Volatility in forex markets in 2025

Explore the volatility of the Indian Rupee against the U.S. Dollar in 2025, driven by trade uncertainties and market pressures.

Silver futures jump 6% to record ₹2.54 lakh/kg; cross $80/ounce in global markets

Silver futures soar 6% to ₹2.54 lakh/kg, crossing $80/ounce globally amid bullish trends and strong investor demand.

Stock markets gather momentum after muted beginning

Stock markets gained momentum after a slow start, with Sensex rising 105.17 points and Nifty up 35 points.

Rupee falls 5 paise to 89.95 against U.S. dollar in early trade

Rupee dips 5 paise to 89.95 against the dollar amid foreign fund outflows and a sluggish equity market opening.

IndiGo to begin flight services from Tamil Nadu to Navi Mumbai airport from December 29

Direct flights from Chennai and Coimbatore to Navi Mumbai airport start December 29, enhancing travel options for passengers.

Survey reveals the dark side of loan recovery in India

Survey highlights alarming harassment practices by banks in India, revealing widespread intimidation and threats during loan recovery efforts.

Akum Pharma’s Finance chief Rajkumar Bafna resigns citing pollution in Delhi

Akum Pharma's finance chief Rajkumar Bafna resigns, citing Delhi's severe pollution as his reason for departure.

SBI, Reliance, top-10 firms see ₹35,439 crore market cap drop

Seven of India’s top-10 firms saw a combined market cap drop of ₹35,439.36 crore last week, led by SBI and Reliance Industries, while HDFC Bank, Infosys gained.

PM Office directs Coal India to list all subsidiaries by 2030

PMO directs Coal India to list all subsidiaries by 2030 to improve governance, transparency, and unlock asset value.

What are the signals from the Indian economy? | Explained Premium

The Hindu explains: What are the signals from the Indian economy?

© 2008 - 2025 Webjosh  |  News Archive  |  Privacy Policy  |  Contact Us